Trial · NCT03267940
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Run-in Portion: Number of Participants With Adverse Events (AEs) | Run-in Portion: PEGCISGEM | 9 | Participants | ||
| Run-in Portion: Number of Participants With Adverse Events (AEs) | Run-in Portion: PEGCISGEMATEZO | 9 | Participants | ||
| Run-in Portion: Number of Participants With Clinically Significant Abnormalities in Laboratory Parameters (Hematology and Blood Chemistry) | Run-in Portion: PEGCISGEM | 0 | Participants | ||
| Run-in Portion: Number of Participants With Clinically Significant Abnormalities in Laboratory Parameters (Hematology and Blood Chemistry) | Run-in Portion: PEGCISGEMATEZO | 0 | Participants | ||
| Run-in Portion: Number of Participants With AEs Leading to Dose Reduction or Interruption of Any Study Medication | Run-in Portion: PEGCISGEM | 6 | Participants | ||
| Run-in Portion: Number of Participants With AEs Leading to Dose Reduction or Interruption of Any Study Medication | Run-in Portion: PEGCISGEMATEZO | 7 | Participants | ||
| Expansion Portion: Number of Participants With AEs | Expansion Portion: PEGCISGEM | 24 | Participants | ||
| Expansion Portion: Number of Participants With AEs | Expansion Portion: PEGCISGEMATEZO Twice Weekly | 22 | Participants | ||
| Expansion Portion: Number of Participants With AEs | Expansion Portion: PEGCISGEMATEZO Once Weekly/Twice Weekly | 10 | Participants | ||
| Expansion Portion: Number of Participants With AEs | Expansion Portion: CISGEM | 10 | Participants | ||
| Expansion Portion: Number of Participants With Clinically Significant Abnormalities in Clinical Laboratory Parameters (Hematology and Blood Chemistry) | Expansion Portion: PEGCISGEM | 0 | Participants | ||
| Expansion Portion: Number of Participants With Clinically Significant Abnormalities in Clinical Laboratory Parameters (Hematology and Blood Chemistry) | Expansion Portion: PEGCISGEMATEZO Twice Weekly | 0 | Participants | ||
| Expansion Portion: Number of Participants With Clinically Significant Abnormalities in Clinical Laboratory Parameters (Hematology and Blood Chemistry) | Expansion Portion: PEGCISGEMATEZO Once Weekly/Twice Weekly | 0 | Participants | ||
| Expansion Portion: Number of Participants With Clinically Significant Abnormalities in Clinical Laboratory Parameters (Hematology and Blood Chemistry) | Expansion Portion: CISGEM | 0 | Participants | ||
| Expansion Period: Number of Participants With AEs Leading to Dose Reduction or Interruption of Any Study Medication | Expansion Portion: PEGCISGEM | 16 | Participants | ||
| Expansion Period: Number of Participants With AEs Leading to Dose Reduction or Interruption of Any Study Medication | Expansion Portion: PEGCISGEMATEZO Twice Weekly | 21 | Participants | ||
| Expansion Period: Number of Participants With AEs Leading to Dose Reduction or Interruption of Any Study Medication | Expansion Portion: PEGCISGEMATEZO Once Weekly/Twice Weekly | 4 | Participants | ||
| Expansion Period: Number of Participants With AEs Leading to Dose Reduction or Interruption of Any Study Medication | Expansion Portion: CISGEM | 7 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03267940/results